Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deshiré Alpizar-Rodriguez

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Journal of Rheumatology|December 3, 2019
Menopause and Possible Effect on Association Between Age and Anticyclic Citrullinated Peptide Antibodies in Women At Risk of Rheumatoid ArthritisDeshiré Alpizar-Rodriguez, Axel Finckh
Clinical Rheumatology|February 5, 2020
Is the prevention of rheumatoid arthritis possible?Deshiré Alpizar-Rodriguez, Axel Finckh
Rheumatology (Oxford, England)|November 12, 2019
Are cardiovascular events and mortality in patients with systemic lupus erythematosus predictable at diagnosis?Deshiré Alpizar-Rodriguez, Juanita Romero-Diaz
Revue Medicale Suisse|March 8, 2018
[Microbiota and inflammatory rheumatisms]Matthias Jarlborg, Deshiré Alpizar-Rodriguez, Athan Baillet, et al.
Nature Reviews. Rheumatology|September 6, 2022
Global epidemiology of rheumatoid arthritisAxel Finckh, Benoît Gilbert, Bridget Hodkinson, et al.
International Journal of Immunogenetics|January 22, 2021
Identification of biological pathways specific to phases preceding rheumatoid arthritis development through gene expression profilingCyril Dalmasso, Céline Derbois, Maëva Veyssiere, et al.
Rheumatology (Oxford, England)|September 2, 2017
Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritisDeshiré Alpizar-Rodriguez, Rüdiger B Mueller, Burkhard Möller, et al.
Advances in Rheumatology (London, England)|October 10, 2024
Socioeconomic factors and COVID-19 mortality in immune-mediated rheumatic diseases patients: regional analysis from Argentina, Mexico and BrazilMarco Ulises Martinez-Martinez, Carolina Ayelen Isnardi, Deshiré Alpizar-Rodriguez, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Journal of Rheumatology|December 3, 2019
Menopause and Possible Effect on Association Between Age and Anticyclic Citrullinated Peptide Antibodies in Women At Risk of Rheumatoid ArthritisDeshiré Alpizar-Rodriguez, Axel Finckh
Clinical Rheumatology|February 5, 2020
Is the prevention of rheumatoid arthritis possible?Deshiré Alpizar-Rodriguez, Axel Finckh
Rheumatology (Oxford, England)|November 12, 2019
Are cardiovascular events and mortality in patients with systemic lupus erythematosus predictable at diagnosis?Deshiré Alpizar-Rodriguez, Juanita Romero-Diaz
Revue Medicale Suisse|March 8, 2018
[Microbiota and inflammatory rheumatisms]Matthias Jarlborg, Deshiré Alpizar-Rodriguez, Athan Baillet, et al.
Nature Reviews. Rheumatology|September 6, 2022
Global epidemiology of rheumatoid arthritisAxel Finckh, Benoît Gilbert, Bridget Hodkinson, et al.
International Journal of Immunogenetics|January 22, 2021
Identification of biological pathways specific to phases preceding rheumatoid arthritis development through gene expression profilingCyril Dalmasso, Céline Derbois, Maëva Veyssiere, et al.
Rheumatology (Oxford, England)|September 2, 2017
Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritisDeshiré Alpizar-Rodriguez, Rüdiger B Mueller, Burkhard Möller, et al.
Advances in Rheumatology (London, England)|October 10, 2024
Socioeconomic factors and COVID-19 mortality in immune-mediated rheumatic diseases patients: regional analysis from Argentina, Mexico and BrazilMarco Ulises Martinez-Martinez, Carolina Ayelen Isnardi, Deshiré Alpizar-Rodriguez, et al.
Pageof 1